Effects of CPAP vs. High Flow Nasal Oxygen in ARDS Patients
Official title: Physiologic Effects of Two Non-invasive Respiratory Support Therapies (continuous Positive Airway Pressure Vs High Flow Nasal Oxygenation) in Patients with Acute Respiratory Distress Syndrome: a Randomized Clinical Trial.
Run by Hospital Clinic of Barcelona · NCT06694311 · Data updated 2026-11-12
This study is testing whether using CPAP or high flow nasal oxygen helps people with acute respiratory distress syndrome breathe better and recover faster.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Hospital Clinic of Barcelona Academic / other |
| Locations | 1 site (Barcelona, Barcelona) |
| Status | Recruiting |
| Started | January 7, 2025 |
| Main results expected | April 30, 2026 |
| Study ends | July 31, 2027 |
| Registry record updated | January 15, 2025 |
| Trial ID | NCT06694311 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are non-intubated patients aged 18 to 80 with ARDS and specific oxygenation criteria.
✕Probably not a fit
Patients with chronic respiratory failure, significant nasal obstruction, or those who have received invasive ventilation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the physiological effects of continuous positive airway pressure (CPAP) compared to high flow nasal oxygenation (HFNO) in patients suffering from acute respiratory distress syndrome (ARDS). It is a multicenter, randomized, open-label, controlled trial involving 120 non-intubated patients who will receive either CPAP or HFNO for 48 hours alongside standard intensive care. The primary outcome is the assessment of lung injury through the biomarker sRAGE, while secondary outcomes include various pulmonary dysfunction biomarkers and intubation rates. The study aims to determine if CPAP can effectively reduce lung injury and improve clinical outcomes compared to HFNO.
Why it matters
Potential benefit: If successful, this study could provide insights into more effective non-invasive respiratory support options for ARDS patients, potentially reducing the need for intubation.
How similar studies have gone: Previous studies have shown that CPAP may be effective in reducing patient self-inflicted lung injury compared to HFNO, but this specific comparison in ARDS patients is still under investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * PaO2/FiO2 ratio \<300 mmHg with FiO2 \>40% and PEEP ≥5 cmH2O (CPAP) or flow ≥30 L/min (HFNC). * Bilateral pulmonary opacities observed in the chest X-ray, thoracic computerized tomography (CT) scan or lung ultrasonography (bilateral B lines) * \<7 days from the pulmonary insult to symptom onset and criteria 1 and 2 * Not meeting the aforementioned criteria for \>24 hours prior to study inclusion. Exclusion Criteria: * Age \<18 years or \>80 years * History of chronic respiratory failure or interstitial pulmonary disease * Acute cardiogenic pulmonary edema after echocardiographic evaluation * Having received either invasive mechanical ventilation or non-invasive mechanical ventilation (NIV) * Atelectasis, pleural effusion, pulmonary masses or nodules as the primary finding in thoracic imaging. * "Do not intubate, do not resuscitate" orders * Presenting significant nasal obstruction.
Where it's running
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, Spain Recruiting
Study contacts
- Study coordinator: Ricard Mellado Artigas, PhD
- Email: rmellado@clinic.cat
- Phone: +34 646217716
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding immune patterns and ECMO strategies to help adults with severe ARDS
This study tests how different immune and clinical patterns in adults with moderate-to-severe ARDS respond to ECMO and lung-protective care, aiming to improve outcomes.
-
Optimal corticosteroid dosing for ARDS: short vs. prolonged therapy
This trial tests different corticosteroid doses and treatment lengths to see which helps adults with ARDS who are on ventilators.
-
Lateral positioning to optimize breathing in adults after abdominal surgery with ARDS
This study tests whether lying on the left or right side helps improve lung function in adults who developed ARDS after abdominal surgery, using a bedside imaging test to watch ventilation and blood flow while changing positions.
-
Dexamethasone for sepsis-related ARDS in adults on ventilatory support
This trial tests whether dexamethasone can help adults with sepsis-associated ARDS on ventilators recover better compared to placebo.
-
NIRS for EDResp: Which first helps hypoxemic adults best?
This trial tests whether non-invasive ventilation with a mask (NIPPV) or high-flow nasal oxygen (HFNO) is more helpful for adults in the emergency department with acute hypoxemic respiratory failure.
-
Sodium bicarbonate with bedside electrical impedance tomography to map lung blood flow in ventilated adults
This project will try whether a small sodium bicarbonate injection combined with bedside electrical impedance tomography can map lung blood flow in adults on mechanical ventilation, compared with hypertonic saline.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.